St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that alert the rest of the immune system to the presence of cancer - and how restoring ...
New findings from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM), published in ...
St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that alert the rest of the immune system to the presence of cancer—and how restoring their ...
In solid tumours, such as breast and colon cancers, dendritic cells are not only rare but also defective. Without functional ...
April 02, 2026) St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that ...
For his work towards developing a novel cancer immunotherapy that turns tumors into their own vaccines, Fábio Rosa has ...
Engineered immune cells spark cancer immunotherapy hope, following metabolic by-products secreted by cancer cells to ...
Morning Overview on MSN
Metabolic enzyme may predict who benefits from cancer immunotherapy
A metabolic enzyme found in the support cells surrounding tumors may hold the key to predicting which cancer patients will ...
Starting treatment of study participants in the RASolute 303 trial represents an important milestone for our daraxonrasib program and for patients with metastatic pancreatic cancer, a disease with ...
Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat ...
Vaping devices, or e-cigarettes, are becoming more popular in the United States, especially among young people. These ...
Cancer treatment is undergoing a major transformation driven by advances in precision oncology, in which biomarkers play a central role in guiding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results